Duchenne Muscular Dystrophy (DMD) Treatment Market to Reap Excessive Revenues by 2025


Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin protein, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing.  Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the complications of this disease. The treatment is available to control or reduce the signs and symptoms as DMD is not curable. Steroid drugs are used to control the symptoms of duchenne muscular dystrophy. Stem cell therapy and gene therapy could be used for treatment of this disease in future.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/898

Growing investments in the research and development, to find out effective treatment for DMD is driving the growth of duchenne muscular dystrophy (DMD) treatment market

According to the reports of Centers for Disease Control and prevention (CDC) 2007, 349 out of 2.37 million males in the United States were reported to be suffering from DMD. Whereas in 2019, 349 new cases of DMD were reported. Increasing incidences of DMD and requirement for its treatment is driving the growth of duchenne muscular dystrophy treatment market. Various organizations are involved in spreading awareness and investing in research and development to find the effective treatment for this disease, which is contributing to the growth of duchenne muscular dystrophy treatment market. For instance, Muscular Dystrophy Association (MDA), U.S. invests 75000 USD in research and development to find out the treatment for duchenne muscular dystrophy and the association funds more than 150 care centers, health care facility centers, and hospitals across U.S. and other countries. Moreover, other factors, such as constant research on stem cell therapy, gene therapy, and exon skipping drugs for the treatment of DMD is expected to propel the growth of DMD treatment market. However, major restraints hampering the growth of duchenne muscular dystrophy treatment market are, low seeking rate due to prognosis and late diagnosis of this disease.

Click To Continue Reading on Duchenne Muscular Dystrophy (DMD) Treatment Market


Comments are closed.